Barry Richard's Form 4 filing
Filana Therapeutics, Inc. (FLNA) · filed Sep 22, 2025
- Accession no.
- 0001437749-25-029586
- Filed
- Sep 22, 2025
- Trade date
- Sep 18-19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $534.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barry RichardCIK 0001562371 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Common Stock | PPurchaseAcquired | +5,400 | $2.13 | +$11,502 | 474,962 | Indirect | |
| Sep 18, 2025 | Common Stock | PPurchaseAcquired | +185,233 | $2.24 | +$414,921.92 | 660,195 | Indirect | |
| Sep 19, 2025 | Common Stock | PPurchaseAcquired | +400 | $2.25 | +$900 | 660,595 | Indirect | |
| Sep 19, 2025 | Common Stock | PPurchaseAcquired | +46,908 | $2.29 | +$107,419.32 | 707,503 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.